Posted On: 11/16/2015 9:41 AM
TITAN 3002– A study of investigational drug for metastatic prostate cancer
1. Male age 18 or over
2. Prostate cancer with evidence of metastatic disease on imaging
3. Meet PSA criteria
Sponsored by: Janssen
Length of Study: 2 years
Please contact one of our Clinical Research Coordinators today to find out more information if you are interested in this trial.
Research Department (315) 478-4185, option 7
Our Investigator for this study is Christopher Pieczonka, M.D.